FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Avelumab 200mg/10ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyproterone 100mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Palbociclib 100mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Daratumumab 1.8g/15ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cemiplimab 350mg/7ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyproterone 100mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Necitumumab 800mg/50ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Selpercatinib 80mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Venetoclax 50mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ripretinib 50mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Olaratumab 190mg/19ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cabozantinib 20mg capsules and Cabozantinib 80mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Alpelisib 200mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Neratinib 40mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyproterone 2mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Palbociclib 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cabozantinib 40mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pembrolizumab 50mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Selumetinib 25mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Enfortumab vedotin 30mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Niraparib 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 26 of 26

This concept is not in any reference sets

Back to Start